CompletedNCT04846881
This study exists to learn from real-world information that can show how the medication Iclepertin fits into care. Researchers are trying to understand whether the medication Iclepertin can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Argentina, Brazil, Chile, Croatia, France, Hungary, Japan, Malaysia, Netherlands, Poland, Romania, Serbia, Singapore, Slovakia, South Korea, Spain, Ukraine, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT05741528
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05628103
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT01964404
This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Schizophrenia
CompletedNCT04147897
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.
SchizophreniaOtherFrom 18 Years to 100 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia
CompletedNCT06061952
This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
- Condition
- Schizophrenia
CompletedNCT04779177
This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT04846868
This study exists to learn from real-world information that can show how the medication Iclepertin fits into care. Researchers are trying to understand whether the medication Iclepertin can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, Philippines, Poland, Sweden, Turkey, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT04317807
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 16 Years to 40 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- Schizophrenia
CompletedNCT05227703
This study exists to compare options and see whether the medication CVL-231 offers something meaningfully different. Researchers are trying to understand whether the medication CVL-231 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Hungary, United States
- Sponsor
- AbbVie
- Condition
- Schizophrenia
CompletedNCT06179108
This study exists to compare options and see whether the medication LB-102 offers something meaningfully different. Researchers are trying to understand how people respond to the medication LB-102 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- LB Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedNCT05838625
This study exists to see whether the medication Two can play a useful role in care. Researchers are trying to understand whether the medication Two can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
CompletedNCT06067984
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
CompletedNCT04457310
This study exists to understand what helps blood tests and biological markers work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT04557124
This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand what acceptance and commitment therapy, a talking treatment, could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
SuspendedNCT03930251
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
CompletedNCT01499563
This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand how people respond to the medication ITI-007 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT00587561
This study exists to see whether a guided support group can make care clearer and more responsive. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- VA Connecticut Healthcare System
- Condition
- Schizophrenia
CompletedNCT05538832
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT02469155
This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand what the medication ITI-007 could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT02282761
This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand what the medication ITI-007 could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT00539071
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Northwestern University
- Condition
- Schizophrenia
CompletedNCT07190352
This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
CompletedNCT05273164
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 45 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
TerminatedNCT06002958
This study exists to see whether a guided support group can play a useful role in care. Researchers are trying to understand whether a guided support group can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia